Phase II trial of rucaparib maintenance in metastatic endometrial cancer completes follow-up
Can a maintenance drug help keep advanced endometrial cancer at bay?
A phase II randomized controlled trial evaluated rucaparib maintenance versus placebo in 79 patients with metastatic/recurrent endometrial c…
A trial testing rucaparib as maintenance therapy for advanced endometrial cancer has finished, but results on whether it delays cancer growt…
